K
Kim J. Burchiel
Researcher at Oregon Health & Science University
Publications - 318
Citations - 18198
Kim J. Burchiel is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Trigeminal neuralgia & Deep brain stimulation. The author has an hindex of 68, co-authored 313 publications receiving 16910 citations. Previous affiliations of Kim J. Burchiel include United States Department of Veterans Affairs & University of Washington.
Papers
More filters
Journal ArticleDOI
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial
Frances M. Weaver,Frances M. Weaver,Kenneth A. Follett,Matthew B. Stern,Matthew B. Stern,Kwan Hur,Crystal L. Harris,William J. Marks,William J. Marks,Johannes C. Rothlind,Johannes C. Rothlind,Oren Sagher,Domenic J. Reda,Claudia S. Moy,Rajesh Pahwa,Kim J. Burchiel,Kim J. Burchiel,Penelope Hogarth,Penelope Hogarth,Eugene C. Lai,Eugene C. Lai,John E. Duda,John E. Duda,Kathryn L. Holloway,Kathryn L. Holloway,Ali Samii,Stacy Horn,Jeff M. Bronstein,Gatana Stoner,Jill Heemskerk,Grant D. Huang +30 more
TL;DR: Deep brain stimulation was more effective than best medical therapy in improving on time without troubling dyskinesias, motor function, and quality of life at 6 months, but was associated with an increased risk of serious adverse events.
Journal ArticleDOI
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.
Kenneth A. Follett,Kenneth A. Follett,Frances M. Weaver,Matthew B. Stern,Kwan Hur,Crystal L. Harris,Ping Luo,William J. Marks,Johannes C. Rothlind,Oren Sagher,Claudia S. Moy,Rajesh Pahwa,Kim J. Burchiel,Kim J. Burchiel,Penelope Hogarth,Eugene C. Lai,John E. Duda,Kathryn L. Holloway,Ali Samii,Stacy Horn,Jeff M. Bronstein,Gatana Stoner,Philip A. Starr,Richard K. Simpson,Gordon H. Baltuch,Antonio A.F. De Salles,Grant D. Huang,Domenic J. Reda +27 more
TL;DR: Patients with Parkinson's disease had similar improvement in motor function after either pallidal or subthalamic stimulation, and nonmotor factors may reasonably be included in the selection of surgical target for deep-brain stimulation.
Journal ArticleDOI
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Anthony E. Lang,Steven S. Gill,Nik K. Patel,Andres M. Lozano,John G. Nutt,Richard D. Penn,David J. Brooks,Gary Hotton,Elena Moro,Peter Heywood,Matthew Brodsky,Kim J. Burchiel,Patrick J. Kelly,Arif Dalvi,Burton L. Scott,Mark Stacy,Dennis A. Turner,V. G. Frederich Wooten,W. J. Elias,Edward R. Laws,Vijay Dhawan,A. Jon Stoessl,James Matcham,Robert J. Coffey,Michael Traub +24 more
TL;DR: This randomized controlled clinical trial was designed to confirm initial clinical benefits observed in a small, open‐label trial using intraputamenal (Ipu) infusion of recombinant human GDNF (liatermin).
Journal ArticleDOI
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
J. G. Nutt,Kim J. Burchiel,Cynthia L. Comella,Joseph Jankovic,Anthony E. Lang,Edward R. Laws,Andres M. Lozano,Richard D. Penn,Richard K. Simpson,Mark Stacy,G.F. Wooten +10 more
TL;DR: GDNF administered by ICV injection is biologically active as evidenced by the spectrum of AE encountered in this study, and did not improve parkinsonism, possibly because GDNF did not reach the target tissues—putamen and substantia nigra.
Journal ArticleDOI
AAN-EFNS guidelines on trigeminal neuralgia management.
Giorgio Cruccu,Gary S. Gronseth,John F. Alksne,C. Argoff,Michael Brainin,Kim J. Burchiel,Turo Nurmikko,Joanna M Zakrzewska +7 more
TL;DR: Carbamazepine or oxcarbazepine should be offered as first‐line treatment for pain control and microvascular decompression may be considered over other surgical techniques to provide the longest duration of pain freedom in patients with TN.